| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cost of Revenue | $249.9M | +60.6% |
| Gross Profit | -$214.1M | -104.3% |
| R&D Expense | $208.2M | -24.0% |
| SG&A Expense | $198.8M | -46.3% |
| Operating Income | -$649.8M | +13.2% |
| Pre-tax Income | -$848.2M | -11.1% |
| Income Tax | $12K | +100.0% |
| Net Income | -$966.3M | -23.2% |
| EPS (Basic) | -$1.21 | +32.0% |
| EPS (Diluted) | -$1.21 | +32.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $464.7M | +99.1% |
| Accounts Receivable | $18.0M | -43.7% |
| Inventory | $62.6M | -49.2% |
| Current Assets | $572.4M | +31.0% |
| Total Assets | $1.27B | +3.1% |
| Current Liabilities | $260.1M | -32.2% |
| Long-term Debt | $269.3M | -7.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$496.2M | +14.0% |
| Capital Expenditures | $120.5M | -28.4% |
| Investing Cash Flow | -$66.7M | +69.8% |
| Financing Cash Flow | $743.0M | +24.1% |
| Free Cash Flow | -$616.7M | +17.2% |
| Total Liabilities |
| $555.7M |
| -21.8% |
| Stockholders' Equity | $719.2M | +36.6% |